Canada markets open in 7 hours 36 minutes

Abbott Laboratories (ABT)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
112.44-3.05 (-2.64%)
At close: 04:00PM EDT
112.46 +0.02 (+0.02%)
After hours: 07:59PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close115.49
Open115.35
Bid0.00 x 900
Ask0.00 x 1200
Day's Range112.29 - 115.76
52 Week Range89.67 - 121.64
Volume12,965,346
Avg. Volume5,252,820
Market Cap195.104B
Beta (5Y Monthly)0.74
PE Ratio (TTM)34.49
EPS (TTM)3.26
Earnings DateApr 17, 2024 - Apr 22, 2024
Forward Dividend & Yield2.20 (1.96%)
Ex-Dividend DateApr 12, 2024
1y Target Est125.74
  • Zacks

    Abbott (ABT) is a Top-Ranked Momentum Stock: Should You Buy?

    Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

  • Yahoo Finance Video

    Reckitt Benckiser stock sinks on $60M baby formula verdict

    Reckitt Benckiser Group (RBGLY) shares are taking a noticeable hit after an Illinois jury awarded a mother $60 million in a lawsuit, where she argued one of the British consumer goods company's baby formula brands led to the death of her baby. Yahoo Finance Live reports on Reckitt's declining stock and the broader implications this news is having on Abbott Laboratories (ABT), who also produces baby formula products. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live. Editor's note: This article was written by Luke Carberry Mogan.

  • Investor's Business Daily

    Why Abbott's Formula-Related Sell-Off Could Be A Buying Opportunity, Says Analyst

    Abbott stock tumbled to a month-low Friday after an Illinois jury ordered Reckitt Benckiser to pay $60 million in an infant formula lawsuit.